|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.60 EUR | +3.27% |
|
-4.97% | -27.14% |
| 05-15 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.35% | -4.87% | +2.42% | +27.80% | +7.63% | +49.87% | +158.67% | +399.69% | +1,341.82% | 1,028B | |
| -2.69% | -6.22% | +4.82% | +3.50% | +19.36% | +59.19% | +55.29% | +46.71% | +100.83% | 611B | |
| +0.44% | -3.41% | +10.16% | +17.12% | +6.84% | +30.97% | +81.05% | +108.32% | +285.52% | 432B | |
| +0.98% | -1.40% | +1.26% | +4.16% | +0.61% | +29.49% | +23.12% | -7.05% | +29.19% | 323B | |
| -0.34% | -3.10% | +1.48% | +3.09% | +11.31% | +27.00% | +43.66% | +45.55% | +51.84% | 277B | |
| +1.63% | -11.76% | -4.80% | -14.90% | -8.88% | +19.72% | +23.20% | +50.56% | +179.12% | 257B | |
| +3.39% | +2.29% | +15.74% | +31.25% | +1.63% | -23.68% | -38.33% | +20.11% | +77.76% | 217B | |
| +0.86% | -2.63% | +2.22% | +2.90% | +9.47% | +22.50% | +57.27% | +45.29% | +119.45% | 192B | |
| +1.28% | -3.03% | +5.95% | -5.77% | +7.30% | +20.76% | +69.98% | +92.83% | +51.96% | 161B | |
| +2.35% | +3.20% | -4.54% | -8.72% | -0.32% | +0.85% | -30.79% | -38.09% | -32.50% | 138B | |
| +0.16% | -4.28% | +5.91% | +8.01% | +5.23% | +2.77% | +33.27% | +138.43% | +428.85% | 121B | |
| +3.11% | +2.05% | +4.41% | +1.43% | +8.86% | +26.47% | -5.06% | -12.92% | -22.74% | 116B | |
| +1.01% | +1.18% | +0.95% | -5.98% | -7.81% | -7.79% | -19.01% | -12.50% | +0.83% | 104B | |
| -0.21% | -3.18% | -2.12% | -10.07% | +5.04% | +36.65% | +45.34% | +8.97% | -7.08% | 103B | |
| -1.56% | -6.46% | -4.32% | -16.34% | -13.53% | +3.54% | +84.09% | +68.91% | +451.85% | 73.58B | |
| -2.87% | -3.89% | +31.40% | +17.11% | +28.91% | +74.67% | -5.00% | -5.58% | -49.19% | 55.22B | |
| +4.89% | +3.87% | +18.58% | +2.35% | -3.47% | +0.51% | +21.00% | -4.34% | +261.39% | 53.42B | |
| -0.73% | -2.94% | +4.05% | -5.64% | +9.37% | +21.26% | +22.86% | +39.53% | +19.45% | 51.97B | |
| -0.31% | -1.18% | +7.19% | +1.73% | -4.16% | -1.16% | +13.42% | - | - | 42.52B | |
| Average | +0.71% | -3.68% | +5.30% | +2.79% | +4.39% | +20.72% | +33.37% | +54.69% | +182.69% | 229.3B | |
| Weighted average by Cap. | +0.56% | -4.93% | +4.04% | +9.37% | +6.67% | +31.53% | +64.75% | +128.35% | +410.68% |
- Stock Market
- Stocks
- COLL Stock
- 354 Stock
- Sector Collegium Pharmaceutical, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
